EOFY SALE: iBOTTLE+ NOW $199 — WAS $399. FINAL HOURS · 30-day risk-free trial · Free shipping

Discussion – 

0

Discussion – 

0

Porphyrin-Palladium Hydride MOF Nanoparticles for Tumor-Targeted Photoacoustic Imaging-Guided Hydrogenothermal Therapy of Cancer


Hydrogen Water Studies

CancerNovel Therapy

Porphyrin-Palladium Hydride MOF Nanoparticles for Tumor-Targeted Photoacoustic Imaging-Guided Hydrogenothermal Therapy of Cancer

by Qianjun He, Zhaokui Jin, Penghe Zhao, Yanyuan Wen, Gaoxin Zhou, Han Zhang, Ying Shuai Wang

Abstract:

Hydrogen molecule as important energy gas recently was discovered to have high value in the treatment of many diseases, while the current constraint is low efficacy of stable hydrogen storage and delivery. By virtue of strong hydrogen-binding and catalytic hydrogenation capacity of Pd, here we develop a nanoscale porphyrin-palladium metal-organic framework (Pd-MOF) with highly dispersive Pd atoms as hydrogen carrier to efficiently load highly reductive hydrogen for tumor-targeted photoacoustic imaging (PAI)-guided hydrogenothermal therapy of cancer. The hydrogenated Pd-MOF (PdH-MOF) exhibits high hydrogen loading capacity, sustained hydrogen release profile, high tumor targeting ability, high photothermal effect and excellent PAI performance. Utilizing these unique advantages of PdH-MOF nanoparticles, high efficacy of hydrogenothermal therapy has been achieved by tumor-targeted delivery and PAI-guided therapy and sustained release of high payload of highly reductive hydrogen. This work proposes a new strategy for hydrogen storage, activation, delivery and combined therapy by using MOF as a versatile platform.

Read more:

https://doi.org/10.1039/C9NH00021F

Related Articles:

Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy

The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side…

Year Published: 2023Whole BodyCancer

Hydrogen inhalation enhances autophagy via the AMPK/mTOR pathway, thereby attenuating doxorubicin-induced cardiac…

Aims: Doxorubicin is a drug widely used in clinical cancer treatment, but severe cardiotoxicity limits its clinical application. Autophagy disorder is an important factor in the mechanism of doxorubicin-induced cardiac injury. As the smallest molecule in nature, hydrogen has various…

Year Published: 2023HeartCancer

Hydrogen nanobubbles: A novel approach toward radio-sensitization agents

Background: Ocular melanoma is a rare kind of eye malignancy that threatens the patient’s eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 (106 Ru) ophthalmic plaques…

Year Published: 2023EyeCancer

A drug co-delivery platform made of magnesium-based micromotors enhances combination therapy for…

Combination therapy is an emerging strategy to overcome multidrug resistance (MDR) in hepatocellular carcinoma (HCC) chemotherapy treatment. However, the passive diffusion in traditional delivery systems greatly retards the approach and penetration of drugs into hepatocellular carcinoma cells and thus hinders…

Year Published: 2023LiverCancer

NIR-Activatable Heterostructured Nanoadjuvant Cop/Nicop Executing Lactate Metabolism Interventions for Boosted Photocatalytic Hydrogen…

Near-infrared (NIR) laser-induced photoimmunotherapy has aroused great interest due to its intrinsic non-invasiveness and spatiotemporal precision, while immune evasion evoked by lactic acid (LA) accumulation severely limits its clinical outcomes. Although several metabolic interventions have been devoted to ameliorate immunosuppression,…

Year Published: 2023Whole BodyImmune Regulation

Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer…

Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the world. Tumor removal remains the preferred frontline treatment; however, effective non-surgical interventions remain a high priority. 5-fluorouracil (5-FU) is a widely used chemotherapy agent, and molecular…

Year Published: 2022IntestineCancer

Sam Solomon

Research Scientist at iBottle

0 Comments

Submit a Comment

0
    0
    Your Cart
    Empty CartYour cart is emptyReturn to Shop
    Secure Checkout
    Free Shipping
    30-Day Money-Back